Skip to main content
Have a personal or library account? Click to login
The Most Important Angiogenic Growth Factors Influencing the Development and Function of Blood Vessels - in the Context of Coronary Artery Bypass Grafting (CABG) Cover

The Most Important Angiogenic Growth Factors Influencing the Development and Function of Blood Vessels - in the Context of Coronary Artery Bypass Grafting (CABG)

Medical Journal of Cell Biology
Volume 3 (2011): Issue 3 (October 2011)
By: ,   and    
Open Access
|Oct 2014
References

References

  1. [1] ABRAMOV D, EREZ E, DAGAN O, ABRAMOV Y, PEARL E, VEENA G, KATZ J, VIDNE BA, BARAK V. Increased levels of basic fibroblast growth factors are found in the cross-clamped heart during cardiopulmonary bypass. Can J Cardiol 2000; 16:313-318
    Search in Google Scholar
  2. [2] ALVAREZ R, KANTARJIAN HM, CORTES JE. Biology of plateled-derived growth factor and its involvment in disease. Mayo Clin Proc 2006; 81:1241-1257
    Open DOISearch in Google Scholar
  3. [3] ATTARAN S, SHERWOOD R, DASTIDAR MG, EL-GAMEL A. Identification of low circulatory transforming growth factor β-1 in patients with degenerative heart valce disease. Interact Cardiovasc Thorac Surg 2010; 11;791-793
    Open DOISearch in Google Scholar
  4. [4] BATES DO, HILLMAN NJ, WILLIAMS BJ, NEAL CR, POCOCK TM. Regulation of microvascular permeability by vascular endothelial growth factors. Anat 2002; 200:581-597
    Open DOISearch in Google Scholar
  5. [5] BATTEGAY EJ, RAINES EW, SEIFERT RA, BOWEN-POPE DF, ROSS R. TGF-beta induces bimodal proliferation of connective tissue cells via complex control pf an autocrine PDGF loop. Cell 1990; 63:515-524
    Open DOISearch in Google Scholar
  6. [6] BATTEGAY EJ, RUPP J, IRUELA-ARISPE L, SAGE EH, PECH M. PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF-beta recxeptors. J Cell Biol 1994; 125:917-928
    Open DOISearch in Google Scholar
  7. [7] BERNOTAT-DANIELOWSKI S, SHARMA HS, SCHOTT RJ, SCHAPER W. Generation and localization of monoclonal antibodies against fibroblast growth factors in ischaemic collateralized porcine myocardium. Cardiovasc Res 1993; 27:1220-1228
    Open DOISearch in Google Scholar
  8. [8] BERSE B, BROWN LF, VAN DE WATER L, DVORAK HF, SENGER DR. Vascular permeability factor (vascular endothelial factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell. 1992; 3:211-20
    Open DOISearch in Google Scholar
  9. [9] BRANTON MH, KOPP JB. TGF-β and fibrosis. Microbes Infect 1999; 1:1349-1365
    Open DOISearch in Google Scholar
  10. [10] BURTON PBJ, OWEN VJ, HAFIZI S, BARTON PJR, CARR-WHITE G, KOH T, DE SOUZA A, YACOUB MH, PEPPER JR. Vascular endothelial growth factor release following coronary artery bypass surgery: extracorporeal circulation versus beating heart surgery. Eur Heart J 2000; 21:1708-1713
    Open DOISearch in Google Scholar
  11. [11] CASSCELLS W, SPEIR E, SASSE J, KLAGSBRUN M, ALLEN P, LEE M, CALVO B, CHIBA M, HAGGROTH L, FOLKMAN J, et al. Isolation, characterization, and localization of heparin-binding growth factors in the heart. J Clin Invest 1990; 85:433-441
    Open DOISearch in Google Scholar
  12. [12] CLAFFEY KP, ABRAMS KRISTIN, SHIH SC, BROWN LF, MULLEN A, KEOUGH M. Fibroblast growth factor 2 activation of stromal cell vascular endothelial growth factor expression and angiogenesis. Lab Invest 2001; 81:61-75
    Open DOISearch in Google Scholar
  13. [13] CLAUSS M, GERLACH M, GERLACH H, BRETT J, WANG F, FAMILLETTI PC, PAN Y-C, OLANDER JV, CONNOLLY DT, STERN D. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990; 172:1535-1545
    Open DOISearch in Google Scholar
  14. [14] DAVIS S, ALDRICH TH, JONES PF, ACHESON A, COMPTON DL, JAIN V, RYAN TE, BRUNO J, RADZIEJEWSKI C, MAISONPIERRE PC, YANCOPOULOS GD. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996; 87: 1161-1169
    Open DOISearch in Google Scholar
  15. [15] DĄBEK J, KUŁACH A, MONASTYRSKA-CUP B, GĄSIOR Z. Transforming growth factor β and cardiovascular diseases: the other facet of the „protective cytokine“. Pharmacol Rep 2006; 58:799-805
    Search in Google Scholar
  16. [16] DENIZOT Y, GUGLIELMI L, CORNU E, NATHAN N. Alterations in plasma angiogenic growth factor concentrations after coronary artery bypass graft surgery: relationships with post-operative complications. Cytokine 2003; 24:7-12
    Open DOISearch in Google Scholar
  17. [17] DIMMELER S, DERNBACH E, ZEIHER AM. Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett 2000; 477:258-262
    Open DOISearch in Google Scholar
  18. [18] DVORAK HF. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 2002;20:4368-4380
    Open DOISearch in Google Scholar
  19. [19] FARNEBO F, PIEHL F, LAGERCRANTZ J. Restricted expression pattern of vegf-d in the adult and fetal mouse: high expression in the embryonic lung. Biochem Biophys Res Commun 1999; 257:891-894
    Open DOISearch in Google Scholar
  20. [20] FIEDLER U, SCHARPFENECKER M, KOIDL S, HEGEN A, GRUNOW V, SCHMIDT JM, KRIZ W, THURSTON G, AUGUSTIN HG. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 2004; 103:4150-4256
    Open DOISearch in Google Scholar
  21. [21] FRIEDL R, LI J, SCHUMACHER B, HANKE H, WALTENBERGER J, HANNEKUM A, STRACKE S. Intimal hyperplasia and expression of transforming growth factor-β1 in saphenous veins and internal mammary arteries before coronary artery surgery. Ann Thorac Surg 2004; 78:1312-1318
    Open DOISearch in Google Scholar
  22. [22] FRAZIER AA, QURESHI F, READ KM, GILKESON RC, POSTON RS, WHITE CS. Coronary artery bypass grafts: assessment with multidetector CT in the early and late postoperative settings.Radiographics. 2005; 25:881-896
    Open DOISearch in Google Scholar
  23. [23] FUJITA M, IKEMOTO M, KISHISHITA M, OTANI H, NOHARA R, TANAKA T, TAMAKI S, YAMAZATO A, SASAYAMA S. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation 1996; 94:610-613
    Open DOISearch in Google Scholar
  24. [24] GALE NW, THURSTON G, HACKETT SF, RENARD R, WANG Q, MCCLAIN J, MARTIN C, WITTE C, WITTE MH, JACKSON D, SURI C, CAMPOCHIARO PA, WIEGAND SJ, YANCOPOULOS GD. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 2002; 3:411-423
    Open DOISearch in Google Scholar
  25. [25] GHOSH J, MURPHY MO, TURNER N, KHWAJA N, HALKA A, KIELTY CM, WALKER MG.The role of transforming growth factor β1 in the vascular system. Cardiovasc Pathol 2005; 14:28-36
    Open DOISearch in Google Scholar
  26. [26] GRAINGER DJ, KEMP PR, METCALFE JC, LIU AC, LAWN RM, WILLIAMS NR, GRACE AA, SCHOFIELD PM, CHAUHAN A. The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nat Med 1995; 1:74-79
    Open DOISearch in Google Scholar
  27. [27] GRAINGER DJ. Transforming growth factor β and atherosclerosis: So far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol 2004; 24:399-404
    Open DOISearch in Google Scholar
  28. [28] HASDAI D, BARAK V, LEIBOVITZ E, HERZ I, SCLAROVSKY S, ELDAR M, SCHEINOWITZ M. Serum basic fibroblast growth factor levels in patients with ischemic heart disease. Int J Cardiol 1997; 59:133-138
    Open DOISearch in Google Scholar
  29. [29] HELDIN CH. Structural and functional studies on platelet-derived growth factor. EMBO J 1992; 11:4251-4259
    Open DOISearch in Google Scholar
  30. [30] HELDIN CH, WESTERMARK B. Mechanism of action and in vivo role of plateled-derived growth factor. Physiol Rev 1999; 79:1283-1316
    Open DOISearch in Google Scholar
  31. [31] HOLASH H, MAISONPIERRE PC, COMPTON D, BOLAND P, ALEXANDER CR, ZAGZAG D, YANCOPOULOS GD, WIEGAND SJ. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999; 284:1994-1998
    Open DOISearch in Google Scholar
  32. [32] HOLMES K, ROBERTS OLL, ANGHARAD MT, CROSS MJ. Vascular endothelial growth factor-2: Structure, function, intracellular signalling and therapeutic inhibition. Cellular Signalling 2007; 19:2003-2012
    Open DOISearch in Google Scholar
  33. [33] HUWER H, WELTER C, ÖZBEK C, SEIFERT M, STRAUB U, GREILACH P, KALWEIT G, ISRINGHAUS H. Simultaneous surgical revascularization and angiogenic gene therapy indiffuse coronary artery disease. Eur J Cardiothorac Surg. 2001; 20:1128-1134
    Open DOISearch in Google Scholar
  34. [34] JONES EL, CRAVER JM, GUYTON RA, BONE DK, HATCHER CR JR, RIECHWALD N.Importance of complete revascularization in performance of the coronary bypass operation. Am J Cardiol 1983; 51:7-12
    Open DOISearch in Google Scholar
  35. [35] KOHN S, NAGY JA, DVORAK HF, DVORAK AM. Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels. Lab Invest 1992; 67:596-607
    Search in Google Scholar
  36. [36] KOYAMA H, NISHIZAWA Y, HOSOI M, FUKUMOTO S, KOGAWA K, SHIOI A, MORII H. The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-I. Possible involvement of cyclindependent kinase 2. Circ Res. 1996; 79:757-764
    Open DOISearch in Google Scholar
  37. [37] KUKK E, LYMBOUSSAKI A, TAIRA S, KAIPAINEN A, JELTSCH M, JOUKOV V, ALITALO K.VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role on lymphatic vascular development. Development 1996; 122:3829-3837
    Open DOISearch in Google Scholar
  38. [38] LAHAM RJ, SELLKE FW, EDELMAN AR, PEARLMAN J, WARE A, BROWN DL, GOLD JP, SIMONS M. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 1999; 100:1865-1871
    Open DOISearch in Google Scholar
  39. [39] LAROCHELLE WJ, JEFFERS M, MCDONALD WF, CHILLAKURU RA, GIESE NA, LOKKER NA, SULLIVAN C, BOLDOG FL, YANG M, VERNET C, BURGESS CE, FERNANDES E, DEEGLER LL, RITTMAN B, SHIMKETS J, SHIMKETS RA, ROTHBERG JM, LICHENSTEIN HS. PDGF-D, a new protease-activated growth factor. Nat Cell Biol. 2001; 3:517-521
    Open DOISearch in Google Scholar
  40. [40] LEVIN DC, BECKMANN CF, SOS TA, SNIDERMAN K. Incomplete myocardial reperfusion despite a patent coronary bypass: a generally unrecognized shortcoming of the surgical approach to coronary artery disease. Radiology. 1982; 142:317-321
    Open DOISearch in Google Scholar
  41. [41] LI X, PONTEN A, AASE K, KARLSSON L, ABRAMSSON A, UUTELA M, BÄCKSTRÖM G, HELLSTRÖM M, BOSTRÖM H, LI H, SORIANO P, BETSHOLTZ C, HELDIN CH, ALITALO K, OSTMAN A, ERIKSSON U. PDGF-C is a new protease-activated ligand for the PDGF alphareceptor. Nat Cell Biol. 2000; 2:302-309
    Open DOISearch in Google Scholar
  42. [42] LINDAHL P, JOHANSSON BR, LEVEEN P, BETSHOLTZ C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997; 277:242-245
    Open DOISearch in Google Scholar
  43. [43] LOBOV IB, BROOKS PC, LANG RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA 2002; 99:11205-11210
    Open DOISearch in Google Scholar
  44. [44] LYTTLE DJ, FRASER KM, FLEMING SB, MERCER AA, ROBINSON AJ. Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. J Virol 1994; 68:84-92
    Open DOISearch in Google Scholar
  45. [45] MELDER RJ, KOENIG GC, WITWER BP, SAFABAKHSH N, MUNN LL, JAIN RK. During angiogenesis, vascular endothelial growrh factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nature Med 1996; 2:992-997
    Open DOISearch in Google Scholar
  46. [46] METAIS C, LI J, LI J, SIMONS M, SELLKE FW. Effects of coronary artery disease on expression and microvascular response to VEGF. Am J Physiol Heart Circ Physiol 1998; 275:1411-1418
    Open DOISearch in Google Scholar
  47. [47] MUKHERJEE D, BHATT DL, ROE MT, PATEL V, ELLIS SG. Direct myocardial revascularization and angiogenesis-how many patients might be eligible? Am J Cardiol 1999; 84:598-600
    Open DOISearch in Google Scholar
  48. [48] OLOFSSON B, PAJUSOLA K, KAIPAINEN A, VON EULER G, LOUKOV V, SAKSELA O, ORPANA A, PETTERSSON RF, ALITALO K, ERIKSSON U. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad 1996; 93:2576-2581
    Open DOISearch in Google Scholar
  49. [49] PEPPER MS, FERRARA N, ORCI L, MONTESANO R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991; 181:902-906
    Open DOISearch in Google Scholar
  50. [50] PEPPER MS. Transforming growth factor-β: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 1997; 8:21-43
    Open DOISearch in Google Scholar
  51. [51] PERTOVAARA L, KAIPAINEN A, MUSTONEN T, ORPANA A, FERRARA N, SAKSELA O, ALITALO K. Vascular endothelial growth factor is induced in response to transforming growth factorbeta in fibroblastic and epithelial cells. J Biol Chem. 1994; 269:6271-6274
    Open DOISearch in Google Scholar
  52. [52] PICHIULE P, CHAVEZ JC, LAMANNA JC. Hypoxic regulation of angiopoietin-2 expression in endothelial cels. J Biol Chem 2004; 279:12171-12180
    Open DOISearch in Google Scholar
  53. [53] POWERS CJ, MCLESKEY SW, WELLSTEIN A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 2000; 7:165-197
    Open DOISearch in Google Scholar
  54. [54] ROSENGART TK, LEE LY, PATEL SR, et al. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Ann Surg 1999; 230: 466-470
    Open DOISearch in Google Scholar
  55. [55] ROSS R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-809
    Open DOISearch in Google Scholar
  56. [56] RUTHERFORD C, MARTIN W, CARRIER M, ANGGARD EE, FERNS GA. Endogenously elicited antibodies to platelet derived growth factor-BB and platelet cytosolic protein inhibit aortic lesion development in the cholesterol-fed rabbit. Int J Exp Pathol 1997; 78:21-32
    Open DOISearch in Google Scholar
  57. [57] RUTHERFORD C, MARTIN W, SALAME M, CARRIER M, ANGGARD E, FERNS G. Substantial inhibition of neo-intimal response to balloon injury in the rat carotid artery using a combination of antibodies to platelet-derived growth factor-BB and basic fibroblast growth factor. Atherosclerosis 1997; 130:45-51
    Open DOISearch in Google Scholar
  58. [58] SCHNEIDER H, HUSE K. Arterial gene therapy. Lancet 1996; 348:1380-1382
    Open DOISearch in Google Scholar
  59. [59] SCHUMACHER B, PECHER P, VON SPECHT BU, STEGMANN T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 1998; 97:645-650
    Open DOISearch in Google Scholar
  60. [60] SEGHEZZI G, PATEL S, REN CJ, GUALANDRIS A, PINTUCCI G, ROBBINS ES, SHAPIRO RL, GALLOWAY AC, RIFKIN DB, MIGNATTI P. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol 1998; 141:1659-1673
    Open DOISearch in Google Scholar
  61. [61] SELLKE FW, RUEL M. Vascular growth factors and angiogenesis in cardiac surgery. Ann Thorac Surg 2003; 75:685-690
    Open DOISearch in Google Scholar
  62. [62] SHWEIKI D, ITIN A, SOFFER D, KESHET E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359:843-845
    Open DOISearch in Google Scholar
  63. [63] SLAVIN J. Fibroblast growth factors: at the heart of angiogenesis. Cell Biol Int 1995; 19:431-444
    Open DOISearch in Google Scholar
  64. [64] SPORN MB, ROBERTS AB, WAKEFIELD LM, DE CROMBRUGGHE B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol. 1987; 105:1039-1045
    Open DOISearch in Google Scholar
  65. [65] TASHIRO H, SHIMOKAWA H, YAMANOTO K, MOMOHARA M, TADA H, TAKESHITA A. Altered plasma levels of cytokines in patients with ischemic heart disease. Coron Artery Dis 1997; 8:143-147
    Open DOISearch in Google Scholar
  66. [66] THURSTON G. Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell Tissue Res 2003; 314:61-68
    Open DOISearch in Google Scholar
  67. [67] VALENZUELA DM, GRIFFITHS JA, ROJAS J, ALDRICH TH, JONES PF, ZHOU H, MCCLAIN J, COPELAND NG, GILBERT DJ, JENKINS NA, HUANG T, PAPADOPOULOS N, MAISONPIERRE PC, DAVIS S, YANCOPOULOS GD. Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci USA 1999; 96:1904-1909
    Open DOISearch in Google Scholar
  68. [68] VEIKKOLA T, KARKKAINEN M, CLAESSON-WELSH L, ALITALO K. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res 2000; 60:203-212
    Search in Google Scholar
  69. [69] WILSON JM, FERGUSON JJ. Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty. Tex Heart Inst J. 1995; 22:145-161
    Search in Google Scholar
  70. [70] YAMAZAKI Y, TAKANI K, ATODA H, MORITA T. Snake venom vascular endothelail growth factors (VEGFs) exhibit potent activity through their specific recognition of KDR (VEGF receptor 2). J Biol Chem 2003; 278:51985-51988
    Open DOISearch in Google Scholar
  71. [71] YAMAZAKI Y, MORITA T. Molecular and functional diversity of vascular endothelial growth factors. Divers 2006; 10:515-527
    Open DOISearch in Google Scholar
  72. [72] YANCOPOULOS GD, DAVIS S, GALE NW, RUDGE JS, WIEGAND SJ, HOLASH J. Vascularspecific growth factors and blood vessel formation. Nature 2000; 407: 242-248
    Open DOISearch in Google Scholar
  73. [73] ZACHARY I, GLIKI G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 2001; 49:568-581
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10052-011-0004-3 | Journal eISSN: 2544-3577 (formerly 2080-2218)
Journal RSS Feed
Language: English
Page range: 55 - 67
Published on: Oct 15, 2014
Published by: Foundation for Cell Biology and Molecular Biology
In partnership with: Paradigm Publishing Services
Keywords:
coronary artery disease (CAD),
coronary artery bypass grafting (CABG),
angiogenic growth factors
Related subjects:
Life sciences,
Molecular biology,
Biochemistry

© 2014 Karolina Sterzynska, Patrycja Sujka-Kordowska, Wojciech Witkiewicz, published by Foundation for Cell Biology and Molecular Biology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 3 (2011): Issue 3 (October 2011)
Previous article